Tag: technologies

TORONTO, June 24, 2026 (GLOBE NEWSWIRE) -- (TSX: IMP; OTCQB: ITMSF) – Intermap Technologies Corporation (“Intermap” or the “Company”) held its annual general meeting of shareholders (the “Meeting”) on June 24, 2026, at the TMX Market Centre, Bourse Room, located at 120 Adelaide St W, Toronto, Ontario. A total of 22,993,978 Class A common shares of Intermap (“Common Shares”), representing 31.16% of the total Common Shares outstanding, were represented in person or by proxy at the Meeting.

LONDON, Ontario, 25 juin 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc.. (« Aduro » ou la « Société ») (Nasdaq : ADUR) (TSX : ACT) (FSE : 9D5), une société spécialisée dans les technologies propres qui recycle chimiquement les matières premières de plus faible valeur comme les déchets plastiques, le bitume lourd ou les huiles renouvelables pour les transformer en ressources adaptées au XXI^e siècle, a annoncé aujourd’hui, suite à ses communiqués de presse des 10 juin 2026 et 15 juin 2026, la clôture d’un placement privé sans intermédiaire pour un produit brut de 9 155 940,80 dollars canadiens (6 564 810,21 dollars américains) provenant de la vente de 431 884 actions ordinaires (les « actions LIFE ») au prix de 21,20 dollars canadiens (15,20 dollars américains) par action LIFE (l’« Offre LIFE ») en vertu de la Dispense LIFE (telle que définie aux présentes).

New York, N.Y., June 24, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor and technology company focused on developing clean energy solutions, today announced recent and upcoming high-profile engagements with government officials, industry leaders, multilateral organizations, and energy stakeholders across Asia, Africa, Latin America, and the Caribbean as well as a management team update.

TORONTO, Ontario and HAIFA, Israel, June 25, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce today that its wholly owned U.S. subsidiary, Exo-Top Inc. (“Exo-Top”), has entered into a binding memorandum of understanding (the “MOU”) setting out the principal commercial terms for a proposed definitive distribution agreement (the “Definitive Agreement”) with ExoLyra LLC, which operates as an arm’s length third party (“ExoLyra”).

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Stem Cell Culture Media Market size & share revenue was valued at approximately USD 765 Million in 2025 and is expected to reach USD 868 Million in 2026 and is expected to reach around USD 2714 Million by 2035, at a CAGR of 13.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are PAN Biotech GmbH, Sartorius AG, Cytiva, Lonza Group AG, Corning Incorporated, STEMCELL Technologies Inc., FUJIFILM Irvine Scientific Inc., Takara Bio Inc., Miltenyi Biotec B.V. & Co. KG, PromoCell GmbH, Biological Industries Ltd., CellGenix GmbH, Thermo Fisher Scientific Inc., HiMedia Laboratories Pvt. Ltd., Merck KGaA and others.

Fiscal 2026 Net Income Expected Between $15 Million and $18 Million
Adjusted EBITDA Expected between $75 Million and $77 Million, an increase of 26% to 30%
First Day Program Revenues Estimated to Increase 27% to 28%
Board of Directors Declares Quarterly Dividend of $0.08 per Common Share

New partnership will develop and enable AI technology that will reduce energy use and enhance ingredient production